[Federal Register Volume 85, Number 77 (Tuesday, April 21, 2020)]
[Notices]
[Page 22178]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08352]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-596]


Bulk Manufacturer of Controlled Substances Application: Cedarburg 
Pharmaceuticals

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before June 22, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on September 3, 2018, Cedarburg Pharmaceuticals, 870 
Badger Circle, Grafton, Wisconsin 53024-0000 applied to be registered 
as a bulk manufacturer of the following basic class(es) of controlled 
substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols..................     7370  I
Methylphenidate........................     1724  II
Nabilone...............................     7379  II
4-Anilino-N-phenethyl-4-piperidine          8333  II
 (ANPP).
Fentanyl...............................     9801  II
------------------------------------------------------------------------

    The company plans to manufacture bulk active pharmaceutical 
ingredients (API) for distribution to its customers. In reference to 
drug code 7370 (Tetrahydrocannabinols) the company plans to bulk 
manufacture as synthetic. No other activity for this drug code is 
authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08352 Filed 4-20-20; 8:45 am]
BILLING CODE 4410-09-P